J&J Consumer Rides International Sales Growth Gained In Pfizer Acquisition
This article was originally published in The Tan Sheet
Executive Summary
Last year's acquisition of Pfizer's Consumer Healthcare unit drove Johnson & Johnson's consumer products segment revenue and increased the proportion of international sales in OTCs and nutritionals
You may also be interested in...
Zyrtec OTC, New Segments Picked Up From Pfizer Will Be Key Drivers – J&J
Johnson & Johnson is optimistic about potential earnings from an anticipated OTC launch of Zyrtec (cetirizine HCl) allergy medication late in 2007, company Chairman and CEO William C. Weldon said during a Jan. 23 conference call on the firm's 2006 fourth-quarter and full-year earnings
FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns
The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products
FTC Views Testimonials As Efficacy Claims, Senior Attorney Warns
The Federal Trade Commission's senior staff attorney for advertising practices recommends firms stay away from using consumer testimonials to assert the benefits of their products